サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：組織診断市場、シェア、規模、動向、産業分析レポート：製品別、技術別、疾患別、用途別、地域別、セグメント別予測、2024年～2032年
市場調査レポート
商品コード
1421730

組織診断市場、シェア、規模、動向、産業分析レポート：製品別、技術別、疾患別、用途別、地域別、セグメント別予測、2024年～2032年

Tissue Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product ; By Technology; By Disease ; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
組織診断市場、シェア、規模、動向、産業分析レポート：製品別、技術別、疾患別、用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界の組織診断市場規模は2032年までに101億8,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

組織診断は医療分野で重要な役割を果たしており、組織サンプルを分析してがんやその他の疾患を診断することができます。使用される様々な技術の中でも、ヘマトキシリン・エオジン染色（H&E）は、潜在的ながん症例を評価する際の病理学者のゴールドスタンダードとして広く認められています。がんの診断とモニタリングが組織診断の主要用途であるが、他の疾患の診断にも利用できます。この分野は、さまざまなタイプのがんに対してオーダーメイドの治療法を提供する個別化医療に大きな期待を寄せています。

組織診断を活用することで、標的療法を開発し、患者の予後を改善することができます。さらに、病気の再発予防にも役立ちます。例えば、2023年1月、国際がん研究機関（IARC）は、包括的なデジタルガイドであるAtlas of Breast Cancer Early Detectionを発表しました。これは、臨床乳房検査、診断用マンモグラフィ、診断用乳房超音波検査、微細針吸引細胞診、とコア乳房生検への段階的アプローチを提供します。

個別化医療が重視されるようになり、標的治療の選択やモニタリングに役立つ組織ベースの診断検査への需要が高まっています。デジタル病理検査や自動化などの技術の進歩により、組織診断の効率と精度が向上しています。さらに、マルチプレックスアッセイへの注目が高まっており、1つの組織サンプルで複数のバイオマーカーの同時分析が可能となっています。さらに、業界関係者間のパートナーシップやコラボレーションが、イノベーションと包括的なソリューション開発を促進しています。組織診断における人工知能と機械学習の統合は、自動分析と予測能力を可能にすることで、この分野に革命をもたらす態勢を整えています。

組織診断市場レポートハイライト

  • 消耗品セグメントは、予測期間中に最も高い成長を維持すると予測されます。
  • 免疫組織化学法は腫瘍の種類をより高い特異性で区別できるため、2022年には免疫組織化学分野が市場で最大の売上シェアを占める。
  • 病院部門は、2022年に同市場で最大の売上シェアを占めています。その理由は、効率性と有用性の向上により、医師が従来の方法よりも組織診断検査技術を導入しているためです。
  • 北米は、がん罹患率の減少を目的としたがん予防管理研究ネットワークのような公的プログラムにより、2022年の市場において最大の売上シェアを占めています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の組織診断市場別洞察

  • 組織診断-業界スナップショット
  • 組織診断市場力学
    • 促進要因と機会
      • 画像技術の進歩と診断の手頃な価格の向上
      • 個別化された治療法と診断法の成長
    • 抑制要因と課題
      • 研究開発と臨床試験に関連する高額なコスト
  • PESTLE分析
  • 組織診断業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の組織診断市場、技術別

  • 主要調査結果
  • イントロダクション
  • in-situハイブリダイゼーション
  • 一次染色と特殊染色
  • 免疫組織化学
  • デジタルパソロジー
  • その他

第6章 世界の組織診断市場、製品別

  • 主要調査結果
  • イントロダクション
  • 装置
  • 消耗品

第7章 疾患別の世界の組織診断市場

  • 主要調査結果
  • イントロダクション
  • 前立腺がん
  • 乳がん
  • 肺がん
  • 皮膚がん
  • その他

第8章 世界の組織診断市場、最終用途別

  • 主要調査結果
  • イントロダクション
  • 病院
  • 研究
  • 受託研究機関
  • 製薬会社
  • その他

第9章 世界の組織診断市場、地域別

  • 主要調査結果
  • イントロダクション
    • 組織診断市場評価、地域、2019～2032年
  • 組織診断市場-北米
    • 北米：組織診断市場、技術別、2019～2032年
    • 北米：組織診断市場、最終用途別、2019～2032年
    • 北米：組織診断市場、製品別、2019～2032年
    • 北米：組織診断市場、疾患別、2019～2032年
    • 組織診断市場-米国
    • 組織診断市場-カナダ
  • 組織診断市場-欧州
    • 欧州：組織診断市場、技術別、2019～2032年
    • 欧州：組織診断市場、最終用途別、2019～2032年
    • 欧州：組織診断市場、製品別、2019～2032年
    • 欧州：組織診断市場、疾患別、2019～2032年
    • 組織診断市場-英国
    • 組織診断市場-フランス
    • 組織診断市場-ドイツ
    • 組織診断市場-イタリア
    • 組織診断市場-スペイン
    • 組織診断市場-オランダ
    • 組織診断市場-ロシア
  • 組織診断市場-アジア太平洋
    • アジア太平洋：組織診断市場、技術別、2019～2032年
    • アジア太平洋：組織診断市場、最終用途別、2019～2032年
    • アジア太平洋：組織診断市場、製品別、2019～2032年
    • アジア太平洋：組織診断市場、疾患別、2019～2032年
    • 組織診断市場-中国
    • 組織診断市場-インド
    • 組織診断市場-日本
    • 組織診断市場-マレーシア
    • 組織診断市場-インドネシア
    • 組織診断市場-韓国
  • 組織診断市場-中東・アフリカ
    • 中東・アフリカ：組織診断市場、技術別、2019～2032年
    • 中東・アフリカ：組織診断市場、最終用途別、2019～2032年
    • 中東・アフリカ：組織診断市場、製品別、2019～2032年
    • 中東・アフリカ：組織診断市場、疾患別、2019～2032年
    • 組織診断市場-サウジアラビア
    • 組織診断市場-南アフリカ
    • 組織診断市場-イスラエル
    • 組織診断市場-アラブ首長国連邦
  • 組織診断市場-ラテンアメリカ
    • ラテンアメリカ：組織診断市場、技術別、2019～2032年
    • ラテンアメリカ：組織診断市場、最終用途別、2019～2032年
    • ラテンアメリカ：組織診断市場、製品別、2019～2032年
    • ラテンアメリカ：組織診断市場、疾患別、2019～2032年
    • 組織診断市場-メキシコ
    • 組織診断市場-ブラジル
    • 組織診断市場-アルゼンチン

第10章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Abbott
  • Agilent Technologies, Inc.
  • Bio SB
  • BioGenex
  • Becton, Dickinson and Company（BD）
  • Cell Signaling Technology, Inc.
  • Danaher
  • GE Healthcare
  • Histo-Line Laboratories
  • Hologic Inc
  • Merck KGAA
  • Metropolis Healthcare Limited
  • Roche
  • SAKURA FINETEK JAPAN CO., LTD
  • SLEE Medical GMBH
  • Thermo Fisher Scientific Inc.
図表

List of Tables

  • Table 1 Global Tissue Diagnostics Market, by Technology, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Tissue Diagnostics Market, by Product, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Tissue Diagnostics Market, by Disease, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Tissue Diagnostics Market, by End-Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Tissue Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 7 North America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 8 North America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 9 North America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 U.S.: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 12 U.S.: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 13 U.S.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Canada: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Canada: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Canada: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 17 Canada: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 18 Europe: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 19 Europe: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Europe: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 21 Europe: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 22 Germany: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 25 Germany: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 France: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 France: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 28 France: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 29 France: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 30 UK: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 31 UK: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 32 UK: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 33 UK: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 34 Italy: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Italy: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Italy: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 37 Italy: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 42 Spain: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 43 Spain: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 44 Spain: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 45 Spain: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 46 Russia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Russia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Russia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 49 Russia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 54 China: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 55 China: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 56 China: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 57 China: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 58 Japan: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Japan: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Japan: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 61 Japan: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 India: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 India: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 64 India: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 65 India: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 South Korea: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 South Korea: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 76 South Korea: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 77 South Korea: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 78 Latin America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 79 Latin America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 80 Latin America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 81 Latin America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 82 Brazil: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Brazil: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Brazil: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 85 Brazil: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 86 Mexico: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 87 Mexico: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 88 Mexico: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 89 Mexico: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 90 Argentina: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 91 Argentina: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 92 Argentina: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 93 Argentina: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 98 UAE: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 99 UAE: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 100 UAE: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 101 UAE: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 106 South Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 107 South Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 108 South Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 109 South Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 110 Israel: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 111 Israel: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 112 Israel: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 113 Israel: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Tissue Diagnostics Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End-Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Tissue Diagnostics Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End-Use
  • Figure 9. Global Tissue Diagnostics Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Product
  • Figure 11. Global Tissue Diagnostics Market, by Product, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Disease
  • Figure 13. Global Tissue Diagnostics Market, by Disease, 2021 & 2030 (USD Billion)
目次
Product Code: PM4060

The global tissue diagnostics market size is expected to reach USD 10.18 billion by 2032, according to a new study by Polaris Market Research. The report "Tissue Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Technology; By Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Skin Cancer, Others); By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Tissue diagnostics play a crucial role in the medical field, enabling the analysis of tissue samples to diagnose cancer and other disorders. Among the various techniques used, hematoxylin and eosin stain (H&E) is widely regarded as the gold standard by pathologists when evaluating potential cancer cases. While cancer diagnosis and monitoring are the primary applications of tissue diagnostics, they can also be utilized for diagnosing other diseases. This field holds great promise for personalized medicine, offering tailored treatment options for different types of cancers.

By leveraging tissue diagnostics, targeted therapies can be developed, improving patient outcomes. Furthermore, it aids in preventing disease relapses. For instance, In January 2023, The International Agency for Research on Cancer (IARC) introduced the Atlas of Breast Cancer Early Detection, a comprehensive digital guide. It provides a step-by-step approach to clinical breast examination, diagnostic mammography, diagnostic breast ultrasound, fine-needle aspiration cytology, and core breast biopsy.

A growing emphasis on personalized medicine has increased demand for tissue-based diagnostic tests that aid in targeted treatment selection and monitoring. Technological advancements, such as digital pathology and automation, are improving the efficiency and accuracy of tissue diagnostics. Additionally, a rising focus on multiplex assays enables the simultaneous analysis of multiple biomarkers in a single tissue sample. Furthermore, partnerships and collaborations between industry players drive innovation and comprehensive solutions development. Integrating artificial intelligence and machine learning in tissue diagnostics is poised to revolutionize the field by enabling automated analysis and predictive capabilities.

Tissue Diagnostics Market Report Highlights

  • Consumables segment is anticipated to hold the highest growth during the forecast period, due to these are the products are implemented for reliable and accurate tissue analysis.
  • Immunohistochemistry segment accounted for the largest revenue shares of the market in 2022, due to immunohistochemistry technique can be distinguished between tumor types with greater specificity.
  • Hospitals segment is holding the largest revenue shares of the market in 2022, due to physicians are implementing tissue diagnostics testing techniques over conventional methods due to its enhanced efficiency and utility.
  • North America holds the largest revenue shares of the market in 2022, due to public programs like the Cancer Prevention and Control Research Network, aiming to reduce cancer incidence.
  • The global key market players include: Abbott, Agilent Technologies, Inc., Bio SB, BioGenex, Becton, Dickinson and Company (BD), Cell Signaling Technology, Inc., Danaher, GE Healthcare, and others.

Polaris Market Research has segmented the Tissue Diagnostics market report based on product, technology, disease, end-use, and region:

Tissue Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Consumables

Tissue Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • In-situ hybridization
  • Primary & Special Staining
  • Immunohistochemistry
  • Digital Pathology
  • Others

Tissue Diagnostics, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Skin Cancer
  • Others

Tissue Diagnostics, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Research Laboratories
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Other

Tissue Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Tissue Diagnostics Market Insights

  • 4.1. Tissue Diagnostics - Industry Snapshot
  • 4.2. Tissue Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in imaging techniques and improved diagnostics affordability
      • 4.2.1.2. Growth of personalized therapeutics and diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high costs associated with R&D and clinical trials
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Tissue Diagnostics Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Tissue Diagnostics Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. In-situ hybridization
    • 5.3.1. Global Tissue Diagnostics Market, by In-situ hybridization, by Region, 2019-2032 (USD Billion)
  • 5.4. Primary & Special Staining
    • 5.4.1. Global Tissue Diagnostics Market, by Primary & Special Staining, by Region, 2019-2032 (USD Billion)
  • 5.5. Immunohistochemistry
    • 5.5.1. Global Tissue Diagnostics Market, by Immunohistochemistry, by Region, 2019-2032 (USD Billion)
  • 5.6. Digital Pathology
    • 5.6.1. Global Tissue Diagnostics Market, by Digital Pathology, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Tissue Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Tissue Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Tissue Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.4. Consumables
    • 6.4.1. Global Tissue Diagnostics Market, by Consumables, by Region, 2019-2032 (USD Billion)

7. Global Tissue Diagnostics Market, by Disease

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 7.3. Prostate Cancer
    • 7.3.1. Global Tissue Diagnostics Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 7.4. Breast Cancer
    • 7.4.1. Global Tissue Diagnostics Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Lung Cancer
    • 7.5.1. Global Tissue Diagnostics Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Skin Cancer
    • 7.6.1. Global Tissue Diagnostics Market, by Skin Cancer, by Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Tissue Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Tissue Diagnostics Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Tissue Diagnostics Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 8.4. Research Laboratories
    • 8.4.1. Global Tissue Diagnostics Market, by Research Laboratories, by Region, 2019-2032 (USD Billion)
  • 8.3. Contract Research Organizations
    • 8.3.1. Global Tissue Diagnostics Market, by Contract Research Organizations, by Region, 2019-2032 (USD Billion)
  • 8.4. Pharmaceutical Companies
    • 8.4.1. Global Tissue Diagnostics Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
  • 8.3. Other
    • 8.3.1. Global Tissue Diagnostics Market, by Other, by Region, 2019-2032 (USD Billion)

9. Global Tissue Diagnostics Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Tissue Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Tissue Diagnostics Market - North America
    • 9.3.1. North America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.3.2. North America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.3.3. North America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.3.4. North America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.3.5. Tissue Diagnostics Market - U.S.
      • 9.3.5.1. U.S.: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.3.6. Tissue Diagnostics Market - Canada
      • 9.3.6.1. Canada: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.4. Tissue Diagnostics Market - Europe
    • 9.4.1. Europe: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.5. Tissue Diagnostics Market - UK
      • 9.4.5.1. UK: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.6. Tissue Diagnostics Market - France
      • 9.4.6.1. France: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.7. Tissue Diagnostics Market - Germany
      • 9.4.7.1. Germany: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.8. Tissue Diagnostics Market - Italy
      • 9.4.8.1. Italy: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.9. Tissue Diagnostics Market - Spain
      • 9.4.9.1. Spain: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.10. Tissue Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.11. Tissue Diagnostics Market - Russia
      • 9.4.11.1. Russia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.5. Tissue Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.5. Tissue Diagnostics Market - China
      • 9.5.5.1. China: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.6. Tissue Diagnostics Market - India
      • 9.5.6.1. India: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.7. Tissue Diagnostics Market - Japan
      • 9.5.7.1. Japan: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.8. Tissue Diagnostics Market - Malaysia
      • 9.5.8.1. Malaysia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.9. Tissue Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.10. Tissue Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.6. Tissue Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.5. Tissue Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.6. Tissue Diagnostics Market - South Africa
      • 9.6.6.1. South Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.7. Tissue Diagnostics Market - Israel
      • 9.6.7.1. Israel: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.8. Tissue Diagnostics Market - UAE
      • 9.6.8.1. UAE: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.7. Tissue Diagnostics Market - Latin America
    • 9.7.1. Latin America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.5. Tissue Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.6. Tissue Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.7. Tissue Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bio SB
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BioGenex
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Becton, Dickinson and Company (BD)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Cell Signaling Technology, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Danaher
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. GE Healthcare
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Histo-Line Laboratories
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Hologic Inc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Merck KGAA
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Metropolis Healthcare Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Roche
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. SAKURA FINETEK JAPAN CO., LTD
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. SLEE Medical GMBH
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Thermo Fisher Scientific Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development